Retrospective Analysis of the Risk of Hyperkalemia in Women Older Than 65 Years of Age Prescribed Spironolactone for Female-Pattern Hair Loss
October 2022
in “
British Journal of Dermatology
”
Studysummary In this retrospective study, the incidence of hyperkalaemia within the first year of spironolactone use was assessed among women over 65 with female-pattern hair loss, highlighting a potential safety concern.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on academic.oup.com →